| Nov 10 |
IGM Biosciences Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
| Nov 8 |
IGM Biosciences, Inc. (IGMS) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 8 |
IGM Biosciences GAAP EPS of -$1.01 misses by $0.19, revenue of $0.52M beats by $0.28M
|
| Nov 8 |
IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update
|
| Nov 7 |
IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans
|
| Nov 4 |
IGM Biosciences to Present at Three Upcoming Investor Conferences
|
| Oct 1 |
IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO
|
| Oct 1 |
IGM Biosciences downgraded to Hold, stock falls
|
| Oct 1 |
These Stocks Are Moving the Most Today: Boeing, Super Micro, HP Inc., CVS, Ford, NIO, IGM Biosciences, and More
|
| Oct 1 |
Top 1% Biotech, IGM Biosciences, Plummets On Scrapped Drug, C-Suite Makeover
|
